All News

Your daily dose of clinical news you may have missed.

Large study comparing spinal cord stimulators to conventional medical management found a lack of clinical benefit for most patients and possible harm to some.

A daily step count of as few as 3800 was associated with a 25% reduced risk of incident dementia in a cohort of 78 000 adults; the optimal count was fewer than 10 000.

Study participants who had HZ were at 30% greater sustained risk of stroke and CHD vs those who had not had HZ in this large multicohort prospective study.

Racial disparities in maternal, prenatal, and infant care are "stark and unacceptable," say authors of the March of Dimes 2022 Report Card.

One in 7 parents have not discussed vaccines with their child's primary clinician during the 2-year pandemic period, according to a CS Mott Children's Hospital poll.

Allopurinol exposures of 100 mg or more than 100 mg were associated with lower odds of first-ever ACS with some differences between sexes, a new study reports.

The "Plan B" emergency contraceptive at 2 times the normal dose was not more effective in study participants with BMI >30.

Your daily dose of clinical news you may have missed.

The analysis of a large biracial cohort found low levels of HDL-C linked to increased CHD risk in White but not Black adults and high HDL-C was not protective in either group.

Your daily dose of clinical news you may have missed.

Wearable activity trackers could potentially support clinical care for patients with pulmonary arterial hypertension, according to a new study.

Overall flu activity is at a 10-year high, according to the CDC's most recent influenza surveillance report, while US hospitals are already overwhelmed.

Your daily dose of clinical news you may have missed.

Teplizumab, an anti-CD3 monoclonal antibody, delayed the median onset of stage 3 T1D by approximately 2 years compared to placebo in a pivotal clinical trial.

Ordering an obesity phenotype should be as simple and routine as ordering an HbA1c or a lipid panel, says obesity expert Andres Acosta, MD, PhD.

The low rate of stroke prevention with oral anticoagulation in patients with atrial fibrillation is cause for significant concern, say investigators.

A preliminary assessment from the FDA suggests certain naloxone products may be safely used without a prescription to prevent opioid overdose deaths.